New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes
KTRE,
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26…
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26…
Novartis International AG /. Processed and transmitted by Nasdaq Corporate Solutions.
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26…
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26…
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26…
EAST HANOVER, N.J., March 18, 2017 /PRNewswire/ -- Novartis announced today results of a new post-hoc analysis in a subgroup of…
Reuters Health Information By Lisa Rapaport | March 16, 2017 (Reuters Health) - Obese people who get surgery to lose weight…
Surgery patients had an average weight loss of 18.8 kg (41.4 lb) more after one year than obese people who instead relied on…
Obese people who get surgery to lose weight have half the risk of developing heart failure compared to patients who make…
Obese people who get surgery to lose weight have half the risk of developing heart failure compared to patients who make…
(Reuters Health) – Obese people who get surgery to lose weight have half the risk of developing heart failure compared to…
REUTERS: Obese people who get surgery to lose weight have half the risk of developing heart failure compared to patients who…
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S.
“The public health impact of adopting intensive treatment in the right patients is enormous,” says Adam Bress, University of…
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S.
at 1:46 AM Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in…
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S.
Return to Article List Next Article > Article ID: 669200 Released: 9-Feb-2017 11:05 AM EST Source Newsroom: University of Utah…
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
SOURCE Janssen Research
SOURCE Janssen Research
This year the Food and Drug Administration approved Abbott's Absorb™ bioresorbable stent for the heart.
SOURCE Janssen Research
Latest Health NewsThe Latest from HealthDayMore>> Women who work night shifts or do heavy physical labor may be somewhat less…
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
HEALTHMore>> (Source: WTVM) Spinal cord injuries are not considered common on the football field, but they can be dramatic.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
SOURCE Janssen Research
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
Latest Health NewsThe Latest from HealthDayMore>> Women who work night shifts or do heavy physical labor may be somewhat less…
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
SOURCE Janssen Research
SOURCE Janssen Research
Information contained on this page is provided by an independent third-party content provider.
- Patients with either coronary or peripheral artery disease carry significant risk of fatal or debilitating myocardial…
TITUSVILLE, N.J., Feb. 8, 2017 /PRNewswire/ -- Janssen Research
- Rivaroxaban is the only non-vitamin K antagonist oral anticoagulant (NOAC) currently under assessment in this high-risk…
TITUSVILLE, N.J., Feb. 8, 2017 /PRNewswire/ -- Janssen Research
TITUSVILLE, N.J., Feb. 8, 2017 /PRNewswire/ -- Janssen Research
New statistics show the number of people diagnosed with heart failure will rise 46 percent by 2030, a major increase that would…
Cardiovascular disease is still the leading cause of death among Americans. The number of adults who suffer from heart failure…